The healthcare and life sciences (HCLS) industry faces immense pressure to deliver advanced therapies and innovative products to patients worldwide. But monumental challenges hinder fast and effective progress.
For example, on average, the journey from discovery of a compound to a marketed product spans over a decade, with clinical trials alone taking up to seven years and less than 12 percent of assessed compounds succeeding. This lengthy process comes with substantial financial stakes, potentially exceeding $1-2 billion in research and development (R&D) costs for each successful drug.
PwC and Amazon Web Services (AWS) provide tools and services to help advance these evolutions. By integrating diverse functions made possible by cloud technology and generative AI services, including Amazon Bedrock and Amazon SageMaker, HCLS companies can navigate future complexities with greater precision, speed, and effectiveness.
The post Advancing healthcare and life sciences with generative AI appeared first on Whitepaper Repository -.
↧